WU ZHANG
University of Southern California
H-index: 55
North America-United States
Top articles of WU ZHANG
Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer
European Journal of Cancer
2024/2/10
Hiroyuki Arai
H-Index: 15
Yan Yang
H-Index: 13
Joshua Millstein
H-Index: 16
Federico Innocenti
H-Index: 33
Jingyuan Wang
H-Index: 16
Francesca Battaglin
H-Index: 17
Priya Jayachandran
H-Index: 10
Wu Zhang
H-Index: 31
Emil Lou
H-Index: 24
Benjamin A Weinberg
H-Index: 11
John Marshall
H-Index: 3
Sanjay Goel
H-Index: 15
Heinz-Josef Lenz
H-Index: 72
CCR5 and CCL5 gene expression in colorectal cancer: comprehensive profiling and clinical value
Journal for Immunotherapy of Cancer
2024
Francesca Battaglin
H-Index: 17
Joshua Millstein
H-Index: 16
Yan Yang
H-Index: 13
Hiroyuki Arai
H-Index: 15
Jingyuan Wang
H-Index: 16
Federico Innocenti
H-Index: 33
Priya Jayachandran
H-Index: 10
Annika Lenz
H-Index: 3
Wu Zhang
H-Index: 31
Evanthia Roussos Torres
H-Index: 13
Emil Lou
H-Index: 24
Benjamin A Weinberg
H-Index: 11
Heinz-Josef Lenz
H-Index: 72
Single nucleotide polymorphisms (SNPs) in MHC class I and II genes to predict outcome in patients (pts) with metastatic colorectal cancer (mCRC): Data from FIRE-3, MAVERICC …
2023/6/1
Targeting the clock pathway to modulate immune response in MSI-high colorectal cancer (CRC): evidence from a preclinical in vivo model
Cancer Research
2023/4/4
Impact of genetic variants involved in the lipid metabolism pathway on progression free survival in patients receiving bevacizumab-based chemotherapy in metastatic colorectal …
Eclinicalmedicine
2023/3/1
Breast cancer and neurotransmitters: emerging insights on mechanisms and therapeutic directions
2023/2/24
SETD2 gene expression and the molecular landscape of colorectal cancer (CRC).
2023/2/1
Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study
The Lancet Oncology
2023/2/1
Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer
Oncogene
2022/1/5
Hiroyuki Arai
H-Index: 15
Andrew Elliott
H-Index: 12
Joshua Millstein
H-Index: 16
Federico Innocenti
H-Index: 33
Jingyuan Wang
H-Index: 16
Francesca Battaglin
H-Index: 17
Priya Jayachandran
H-Index: 10
Wu Zhang
H-Index: 31
Emil Lou
H-Index: 24
Benjamin A Weinberg
H-Index: 11
Daniel Magee
H-Index: 9
Jian Zhang
H-Index: 6
Heinz-Josef Lenz
H-Index: 72
fdrci: FDR confidence interval selection and adjustment for large-scale hypothesis testing
Bioinformatics Advances
2022/1/1
Germline polymorphisms in genes maintaining the replication fork predict the efficacy of oxaliplatin and irinotecan in patients with metastatic colorectal cancer
British Journal of Cancer
2022/1/1
Neurotransmitter signaling: a new frontier in colorectal cancer biology and treatment
2022/10/21
Germline polymorphisms in genes involved in the antioxidant system predict the efficacy of cetuximab in metastatic colorectal cancer patients enrolled in FIRE-3 trial
Clinical Colorectal Cancer
2022/9/1
Genetic variants involved in the cGAS-STING pathway predict outcome in patients with metastatic colorectal cancer: Data from FIRE-3 and TRIBE trials
European Journal of Cancer
2022/9/1
Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets
Oncogene
2022/6/24
Characterization of TIM3 and its ligands in colorectal cancer.
2022/6/1
Molecular correlates of MAEA expression in colorectal cancer (CRC).
2022/6/1
DEFB1 gene expression and the molecular landscape of colorectal cancer (CRC).
2022/6/1
Comprehensive profiling of clock genes expression in colorectal cancer (CRC).
2023/6/1
Identification and characterization of recurrent neoantigens in upper gastrointestinal (GI) cancers.
2022/1/5
